Update on Paraneoplastic Cerebellar Degeneration.
Loehrer PA, Zieger L, Simon OJ.
Brain Sci. 2021 Oct 26;11(11):1414. doi: 10.3390/brainsci11111414.
Paraneoplastic cerebellar degeneration.
Vernino S.
Handb Clin Neurol. 2012;103:215-23. doi: 10.1016/B978-0-444-51892-7.00013-9.
Immunological Bases of Paraneoplastic Cerebellar Degeneration and Therapeutic Implications.
Yshii L, Bost C, Liblau R.
Front Immunol. 2020 Jun 2;11:991. doi: 10.3389/fimmu.2020.00991. eCollection 2020.
[Paraneoplastic cerebellar degeneration].
Chabriat H, Chen QM, Poisson M, Delattre JY.
Rev Neurol (Paris). 1994;150(2):105-14.
[Paraneoplastic cerebellar degeneration].
Sakai K.
Brain Nerve. 2010 Apr;62(4):357-64.
Paraneoplastic cerebellar degeneration.
Posner JB.
Can J Neurol Sci. 1993 May;20 Suppl 3:S117-22.
Paraneoplastic Cerebellar Degeneration in Diffuse Large B-cell Lymphoma and Review of Associated Onconeural Antibodies.
Saini V, Dhir A, Rudnick AW, Lukas J, Lizarraga KJ, Margolesky J, Heros DO, Hoffman JE.
Clin Lymphoma Myeloma Leuk. 2020 Jun;20(6):e336-e340. doi: 10.1016/j.clml.2020.02.010. Epub 2020 Feb 19.
An Etiological Investigation of Paraneoplastic Cerebellar Degeneration in Ovarian Cancer Patients: A Systematic Review.
Fidahussain AA, Abid A, Paracha AA, Jeevan VE, Rueve J, Engelhardt M, Schrock C, Ghani S, Nair HK.
Cureus. 2022 Nov 6;14(11):e31154. doi: 10.7759/cureus.31154. eCollection 2022 Nov.
Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity.
Panja D, Vedeler CA, Schubert M.
Neuropathol Appl Neurobiol. 2019 Feb;45(2):141-156. doi: 10.1111/nan.12492. Epub 2018 May 24.
Roles of CDR2 and CDR2L in Anti-Yo Paraneoplastic Cerebellar Degeneration: A Literature Review.
Martínez Lozada PS, Mancero Montalvo R, Iturralde Carrillo A, Montesdeoca-Lozada M, Rodas JA, Leon-Rojas JE.
Int J Mol Sci. 2024 Dec 25;26(1):70. doi: 10.3390/ijms26010070.
